JP2022003099A5 - - Google Patents

Download PDF

Info

Publication number
JP2022003099A5
JP2022003099A5 JP2021171358A JP2021171358A JP2022003099A5 JP 2022003099 A5 JP2022003099 A5 JP 2022003099A5 JP 2021171358 A JP2021171358 A JP 2021171358A JP 2021171358 A JP2021171358 A JP 2021171358A JP 2022003099 A5 JP2022003099 A5 JP 2022003099A5
Authority
JP
Japan
Prior art keywords
eye drop
aqueous
aqueous eye
mpa
viscosity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021171358A
Other languages
English (en)
Japanese (ja)
Other versions
JP7614069B2 (ja
JP2022003099A (ja
Filing date
Publication date
Priority claimed from JP2021521065A external-priority patent/JP6966667B2/ja
Application filed filed Critical
Publication of JP2022003099A publication Critical patent/JP2022003099A/ja
Publication of JP2022003099A5 publication Critical patent/JP2022003099A5/ja
Priority to JP2024228577A priority Critical patent/JP2025031918A/ja
Application granted granted Critical
Publication of JP7614069B2 publication Critical patent/JP7614069B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021171358A 2019-08-27 2021-10-20 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 Active JP7614069B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024228577A JP2025031918A (ja) 2019-08-27 2024-12-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019154525 2019-08-27
JP2019154525 2019-08-27
JP2021521065A JP6966667B2 (ja) 2019-08-27 2020-08-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021521065A Division JP6966667B2 (ja) 2019-08-27 2020-08-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024228577A Division JP2025031918A (ja) 2019-08-27 2024-12-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Publications (3)

Publication Number Publication Date
JP2022003099A JP2022003099A (ja) 2022-01-11
JP2022003099A5 true JP2022003099A5 (enExample) 2023-08-25
JP7614069B2 JP7614069B2 (ja) 2025-01-15

Family

ID=74685901

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021521065A Active JP6966667B2 (ja) 2019-08-27 2020-08-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP2021171358A Active JP7614069B2 (ja) 2019-08-27 2021-10-20 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP2024228577A Pending JP2025031918A (ja) 2019-08-27 2024-12-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021521065A Active JP6966667B2 (ja) 2019-08-27 2020-08-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024228577A Pending JP2025031918A (ja) 2019-08-27 2024-12-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Country Status (7)

Country Link
JP (3) JP6966667B2 (enExample)
KR (2) KR102656181B1 (enExample)
CN (2) CN117771172A (enExample)
MY (1) MY209059A (enExample)
PH (1) PH12022550474A1 (enExample)
TW (1) TWI848171B (enExample)
WO (1) WO2021039748A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102472773B1 (ko) * 2018-02-28 2022-11-30 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 및 양이온성 폴리머를 함유하는 안과용 조성물
KR102656181B1 (ko) * 2019-08-27 2024-04-08 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물
EP4316485A4 (en) * 2021-03-30 2025-03-26 Senju Pharmaceutical Co., Ltd. Suspension containing heterocycloide acetamide derivative
CN114646705A (zh) * 2022-03-22 2022-06-21 武汉绿合医药科技有限公司 一种地夸磷索钠滴眼液有关物质含量检测方法
JP7245383B1 (ja) 2022-09-20 2023-03-23 参天製薬株式会社 ジクアホソルまたはその塩を含有する眼科用組成物のpHの低下を抑制する方法
KR20250160050A (ko) 2024-05-03 2025-11-11 삼천당제약주식회사 물리화학적 특성이 개선된 안구건조증 예방 또는 치료용 약학 조성물
CN119970633A (zh) * 2025-03-26 2025-05-13 苏州乐珠制药有限公司 一种地夸磷索钠滴眼液及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0365270A (ja) 1989-07-31 1991-03-20 Kanzaki Paper Mfg Co Ltd 塗布シートの製造方法
JPH0365270U (enExample) 1989-10-31 1991-06-25
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
KR100549904B1 (ko) * 1996-03-27 2006-05-16 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 우리딘트리포스페이트및관련화합물을함유하는섬모운동장해치료용약학조성물
US5900407A (en) * 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds
US6274626B1 (en) * 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
US7147844B2 (en) * 1999-12-27 2006-12-12 Santen Pharmaceutical Co., Ltd. System for stabilizing lacrimal fluid layer
KR100832821B1 (ko) * 2000-05-30 2008-05-28 산텐 세이야꾸 가부시키가이샤 각막 상피 신장 촉진제
JP5154231B2 (ja) * 2005-02-14 2013-02-27 ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッド 快適な眼科用具およびその製造法
PH12013500424B1 (en) * 2010-09-10 2018-07-11 Santen Pharmaceutical Co Ltd Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
US20110052678A1 (en) * 2010-11-05 2011-03-03 Shantha Totada R Method for treating age related macular degeneration
MY161032A (en) * 2010-12-28 2017-04-03 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
KR20120077080A (ko) 2010-12-30 2012-07-10 동우 화인켐 주식회사 광학필름 및 이를 이용한 백라이트 유닛
US20160213708A1 (en) * 2012-01-08 2016-07-28 Medicure Technologies Ltd. Ophthalmic composition
MY169816A (en) * 2012-03-26 2019-05-16 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
JP2015032653A (ja) 2013-08-01 2015-02-16 株式会社東芝 固体撮像装置
JP6267003B2 (ja) 2014-02-27 2018-01-24 参天製薬株式会社 ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤
CA2947065C (en) * 2014-05-07 2022-04-19 Croma-Pharma Gesellschaft M.B.H. Aqueous ophthalmic solution and method for treating dry eye syndrome
MX384935B (es) * 2014-12-25 2025-03-14 Santen Pharmaceutical Co Ltd Solucion oftalmica acuosa.
HK1245651A1 (en) * 2015-06-05 2018-08-31 Santen Pharmaceutical Co., Ltd. Therapeutic agent for dry eye characterized by being to be dropped into eye of dry eye patient wearing soft contact lens
CN107837276A (zh) * 2016-09-19 2018-03-27 刘力 局部给药的药物组合物
KR102472773B1 (ko) * 2018-02-28 2022-11-30 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 및 양이온성 폴리머를 함유하는 안과용 조성물
KR102656181B1 (ko) * 2019-08-27 2024-04-08 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물

Similar Documents

Publication Publication Date Title
JP2022003099A5 (enExample)
JP2020138980A5 (enExample)
JP2013535472A5 (enExample)
RU2010141542A (ru) Низковязкие высокофлокулированные суспензии триамцинолона ацетонида для интравитреальных инъекций
CN104334164A (zh) 基于木糖醇的抗黏膜组合物以及相关方法和组合物
JP2017002035A5 (enExample)
HRP20230929T1 (hr) Stabilni pripravci semaglutida i njihova upotreba
JP2010540619A5 (enExample)
HRP20250792T1 (hr) Formulacije anhidriranog natrij tiosulfata
JP2011513492A5 (enExample)
MY209059A (en) Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone
JP2015535237A5 (enExample)
JP2018529666A5 (enExample)
HU230738B1 (hu) Ketotifén tartalmú szemészeti készítmény
JP2019530729A5 (enExample)
TW201936750A (zh) 具有釋放活性成分能力的水性組成物及可重複使用之隱形眼鏡產品
JP2022082779A5 (enExample)
FI3445331T3 (fi) Säilöntäainevapaita farmaseuttisia oftalmisia koostumuksia
ES2197781B1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
CO2020005939A2 (es) Composiciones acuosas que comprenden bilastina y mometasona
UY39675A (es) Composiciones de concentrado en suspensión plaguicidas que comprenden principio activo de espiropidión y combinación de agente dispersante binario
ES2263623T3 (es) Agentes antisepticos.
MX2022005014A (es) Combinacion de un antagonista de cxcr7 con un modulador del receptor s1p1.
JP2023001184A5 (enExample)
PH12020551194A1 (en) Eye drops in form of solution comprising benzopyran derivative or pharmaceutically acceptable salt thereof